MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
AcelRx Pharmaceuticals P/CF 2011-2026 | ACRX
P/CF Jährlich AcelRx Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.75 | -0.701 | -0.167 | -0.0959 | -4.65 | -2.49 | -4.81 | -2.84 | -3.56 | -7.47 | -7.28 | -123 | -4.46 | -2.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0959 | -123 | -11.9 |
P/CF anderer Aktien in der Arzneimittelhersteller
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
-3.28 | - | - | $ 754 M |  USA |
 |
Canopy Growth Corporation
CGC
|
-0.857 | $ 1.11 | 4.25 % | $ 119 M |  Canada |
 |
Catalent
CTLT
|
40.5 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.694 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
-0.923 | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
0.157 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
-0.135 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
-0.449 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
-7.12 | - | - | $ 142 M | USA |
 |
Evolus
EOLS
|
-6.42 | $ 5.57 | 34.75 % | $ 359 M | USA |
 |
Cronos Group
CRON
|
-20.4 | $ 2.65 | 1.92 % | $ 1.38 B | Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
-15.3 | - | - | $ 2.06 B |  France |
 |
Harrow Health
HROW
|
44.1 | $ 40.0 | 3.61 % | $ 1.47 B | USA |
 |
Jupiter Wellness
JUPW
|
-1.95 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
-9.74 | $ 0.59 | 7.93 % | $ 10.3 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
-145 | $ 3.8 | -17.03 % | $ 53.4 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-2.09 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-2.07 | - | 2.45 % | $ 38.1 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-0.0334 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
-4.34 | $ 3.69 | 5.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
-8.43 | - | -23.39 % | $ 1.76 M | USA |
 |
Organogenesis Holdings
ORGO
|
29.2 | $ 2.93 | 1.92 % | $ 386 M | USA |
 |
Emergent BioSolutions
EBS
|
-0.673 | $ 8.95 | 0.34 % | $ 458 M | USA |
 |
ProPhase Labs
PRPH
|
4.57 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
1.33 | $ 12.19 | 2.48 % | $ 866 M | USA |
 |
Radius Health
RDUS
|
-16.8 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
-3.77 | $ 0.91 | 0.93 % | $ 21.2 M | USA |
 |
Bausch Health Companies
BHC
|
3.28 | $ 5.7 | -0.61 % | $ 2.08 B | Canada |
 |
Lannett Company
LCI
|
0.647 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.7 | - | -39.89 % | $ 27.7 M | USA |
 |
OrganiGram Holdings
OGI
|
-13.3 | $ 1.42 | 3.28 % | $ 402 M | Canada |
 |
Perrigo Company plc
PRGO
|
8.22 | $ 11.66 | 2.42 % | $ 1.61 B | USA |
 |
Sundial Growers
SNDL
|
-0.00572 | $ 1.55 | 1.48 % | $ 3.37 M | Canada |
 |
TherapeuticsMD
TXMD
|
-2.79 | $ 2.25 | 1.35 % | $ 23.5 M | USA |
 |
Pacira BioSciences
PCRX
|
6.22 | $ 22.97 | 3.94 % | $ 1.06 B | USA |
 |
Veru
VERU
|
-4.98 | $ 2.54 | 0.8 % | $ 343 M | USA |
 |
PetIQ
PETQ
|
6.4 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
-9.33 | - | - | $ 1.08 B | USA |
 |
Viatris
VTRS
|
6.34 | $ 14.88 | -0.1 % | $ 17.9 B | USA |
 |
PLx Pharma
PLXP
|
-3.68 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
-133 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
-4.77 | $ 0.74 | -4.01 % | $ 3.19 M | USA |
 |
Relmada Therapeutics
RLMD
|
-3.13 | $ 4.77 | 2.14 % | $ 144 M | USA |
 |
SCYNEXIS
SCYX
|
1.17 | $ 0.76 | 1.21 % | $ 36.4 M | USA |
 |
Solid Biosciences
SLDB
|
-2.26 | $ 6.18 | 3.69 % | $ 252 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-41.6 | $ 2.74 | -0.36 % | $ 3.4 M | USA |
 |
Tricida
TCDA
|
-2.56 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
151 | $ 7.42 | 0.82 % | $ 4.59 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.815 | - | - | $ 55.5 M | USA |